Examining the Representation of Minority Race and Ethnicity Groups in Breast Cancer Clinical Trials in the USA Published 2012-2022.

Race/ethnicity of research subjects were reported in 785 (73.5%) clinical trials ( n = 736,160), with a positive trend of reporting noted from 2012 to 2016 (68.8%; range 63.8–73.6% per year) to 2017–2022 (79.3%; range 67.4–91.7% per year, p < 0.001).

also in 11,005 other papers

Discussion In this study of 1068 USA breast cancer clinical trials published between 2012 and 2022, overall race/ethnicity reporting was 74%, with an increasing trend over time to as high as 92% of studies published in 2022.

also in 63,971 other papers